Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited cash flow reinvestment rate. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Reinvestment Rate of 0.29x as of June 2023, reinvesting €601.56 Million (capex €524.46 Million plus investments €77.10 Million) from operating cash flow of €2.10 Billion. Explore GU5 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Cash flow reinvestment rate of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2024. Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 12 annual periods. Explore how much does Guangzhou Baiyunshan Pharmaceutical Hold reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Reinvestment Rate by Year (2013–2024)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For the full cash flow conversion analysis, see cash efficiency ratio of Guangzhou Baiyunshan Pharmaceutical Hold.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.73x | €5.96 Billion | €3.44 Billion | €1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | €4.74 Billion | €4.10 Billion | €1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | €7.62 Billion | €7.00 Billion | €1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | €1.30 Billion | €5.67 Billion | €1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | €1.39 Billion | €585.19 Million | €876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | €3.63 Billion | €5.02 Billion | €2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | €909.71 Million | €5.22 Billion | €478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | €2.57 Billion | €1.83 Billion | €196.77 Million | ▲ +646.4% |
| 2016 | 0.19x | €477.18 Million | €2.54 Billion | €228.03 Million | ▼ -54.5% |
| 2015 | 0.41x | €800.01 Million | €1.94 Billion | €515.34 Million | ▲ +12.3% |
| 2014 | 0.37x | €641.36 Million | €1.75 Billion | €356.70 Million | ▲ +38.3% |
| 2013 | 0.27x | €354.40 Million | €1.34 Billion | €350.35 Million | — |